 |
|
|
| |
Evaluation of the Drug-Drug Interaction (DDI)
Potential Between Cobicistat-Boosted Protease Inhibitors and Statins
|
| |
| |
Reported by Jules Levin
18th International Workshop on Clinical Pharmacology of Antiviral Therapy, June 14-17, 2017, Chicago
Joseph M. Custodio, Steve K. West, Devi SenGupta, Arian Zari, Rita Humeniuk, Kah Hiing J. Ling, Moupali Das, Brian P. Kearney
Gilead Sciences, Inc., Foster City, CA
Atazanavir/cobicistat prescribing information:
http://packageinserts.bms.com/pi/pi_evotaz.pdf
Darunavir/cobicistat prescribing information:
https://www.prezcobixhcp.com/sites/www.prezcobix.com-hcp/files/prescribing-information-prezcobix.pdf
Atazanavir PI Product Insert - NATAP
www.natap.org/2016/HIV/011916_01.htm
|
| |
|
|
|
|
|
